The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
By 2030, How Much Growth In Market Size Is Expected For The Artificial Intelligence (AI) In Respiratory Diseases Market?
The market size for artificial intelligence (AI) in respiratory diseases has demonstrated consistent growth over recent years. This market is projected to expand from $7.98 billion in 2025 to reach $8.38 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 4.9%. Historically, this expansion has been driven by factors such as a greater occurrence of respiratory illnesses, the increased application of CT and MRI imaging, the progressive digitalization of healthcare information, the early integration of AI-assisted diagnostic tools, and the enhancement of diagnostic capacities within hospitals.
The artificial intelligence (AI) in respiratory diseases market size is anticipated to undergo significant expansion over the next few years. It is projected to climb to $10.19 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.0%. This projected growth during the forecast period stems from factors such as increasing demand for personalized respiratory care, the rising integration of AI with clinical decision support systems, the expansion of remote monitoring for chronic respiratory patients, a growing focus on preventive pulmonology, and advancements in medical imaging AI. Notable trends expected in this period include the increasing use of AI-based imaging analysis, a rising adoption of predictive disease progression models, the growing integration of AI in pulmonary diagnostics, the expansion of remote respiratory monitoring solutions, and an enhanced focus on early disease detection.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13792&type=smp
What Core Drivers Are Transforming The Artificial Intelligence (AI) In Respiratory Diseases Market?
Considering the future trajectory of the respiratory disease market, environmental pollution represents a key factor. This phenomenon involves the introduction of any substance or energy into the environment at a rate that surpasses its capacity for safe dispersion or storage. Artificial intelligence (AI) in respiratory diseases has the capability to considerably diminish the effects of environmental pollution on respiratory health, achieving this through real-time monitoring, personalized risk assessments, informed decision-making, and inventive solutions for individuals and communities alike. To illustrate, in November 2024, data from the Global Carbon Budget, an annual scientific assessment originating from Japan, revealed that fossil carbon dioxide emissions increased to 37.4 billion tonnes, representing a 0.8% rise from the preceding year. Consequently, the rising levels of environmental pollution are a primary driver for the growth of artificial intelligence (AI) within the respiratory disease market.
What Are The Core Segment Classifications In The Artificial Intelligence (AI) In Respiratory Diseases Market?
The artificial intelligence (AI) in respiratory diseases market covered in this report is segmented –
1) By Imaging Type: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Electronic Patient-Reported Outcomes (ePRO)
2) By Indication: Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection
3) By End Use: Hospital, Diagnostic Centers, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Magnetic Resonance Imaging (MRI): Lung Imaging, Thoracic Imaging, Cardiopulmonary Imaging
2) By Computed Tomography (CT) Scan: High-Resolution CT (HRCT), Low-Dose CT, Thoracic CT
3) By Electronic Patient-Reported Outcomes (ePRO): Symptom Tracking, Medication Adherence Monitoring, Quality Of Life Assessments
Which Trends Are Influencing The Direction Of The Artificial Intelligence (AI) In Respiratory Diseases Market?
Leading companies in the artificial intelligence (AI) sector within the respiratory diseases market are pioneering advanced products like N-Tidal devices to observe patients’ tidal breathing. The N-Tidal apparatus quantifies the air volume exchanged during regular respiration, delivering significant information regarding lung function. For example, in August 2023, TidalSense, a UK-based respiratory technology firm, introduced N-Tidal, a regulated AI technology designated for chronic obstructive pulmonary disease (COPD) diagnosis and ongoing care. This innovation integrates N-Tidal’s CO2 sensor data with an artificial intelligence platform to gauge shifts in lung function, striving to enhance the diagnosis and management of this respiratory ailment. Clinical investigations have affirmed the technology’s remarkable accuracy, and it is projected to transform the diagnostic methods for respiratory conditions. This unveiling constitutes a major stride in employing AI for respiratory disease evaluation, presenting a more comfortable and efficient substitute for current diagnostic examinations.
Which Organizations Are Operating Within The Artificial Intelligence (AI) In Respiratory Diseases Market?
Major companies operating in the artificial intelligence (AI) in respiratory diseases market are Siemens Healthineers, Philips Healthcare, GE Healthcare, Verily Life Sciences LLC, DeepMind Health, Merative L.P., Aidoc Medical, Butterfly Network, Infervision, Imagen Technologies, Caption Health, Swaasa AI, VIDA Diagnostics Inc., Enlitic, Thirona B.V., ArtiQ, Icometrix, Aidence, Arterys, PneumoWave Ltd
Access The Complete Artificial Intelligence (AI) In Respiratory Diseases Market Report:
Which Region Accounts For The Highest Share Of The Artificial Intelligence (AI) In Respiratory Diseases Market?
North America was the largest region in the artificial Intelligence (AI) in respiratory diseases market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in respiratory diseases market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Artificial Intelligence (AI) In Respiratory Diseases Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=13792&type=smp
Browse Through More Reports Similar to the Global Artificial Intelligence (AI) In Respiratory Diseases Market 2026, By The Business Research Company
Artificial Intelligence In Healthcare Diagnosis Global Market Report 2026
Ai In Medical Diagnostics Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/ai-in-medical-diagnostics-global-market-report
Artificial Intelligence Ai In Animal Health Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model